SAN FRANCISCO — A novel assay for detecting circulating tumor cells (CTCs) holds potential as a screening test for colorectal cancer, because it detects the disease at an early stage, and even detects ...
Images of positive CT colonography (CTC) screening examination result in an asymptomatic 67-year-old man. Three-dimensional colon map from CTC (left image) shows the location of two sigmoid polyps ...
The potential benefits of using computed tomography (CT) colonography to screen asymptomatic adults aged 50 to 80 years for colorectal cancer outweigh the risks, according to most of the 24 members of ...
Long-term results to estimate final accuracy of the test are awaited, but this trial shows hints of benefit with treatment escalation tailored to MRD status. 94 Similarly, the question of treatment de ...
Celebrex improved DFS in ctDNA-positive colon cancer patients, reducing cancer recurrence and death risk by 37% compared to placebo. ctDNA status post-surgery was highly prognostic of DFS and OS, ...
An illustration of a tumour DNA fragment. The new blood test uses circulating tumour DNA (ctDNA) to precisely identify the stage 3 colon cancer patients that need chemotherapy after surgery. An ...
When I ask people over the age of 45 if they have had a screening colonoscopy for colon cancer, a lot of them answer “no.” And when I ask them if they plan on getting a colonoscopy in the next few ...
CT colonography reduced the incidence of colorectal cancer by up to 75% versus no screening, while stool DNA testing reduced the incidence by 59%. Stool testing was cost-effective relative to no ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback